Type 2 Diabetes Monotherapy: Choosing the Right First Drug and Using It Properly
Monotherapy in type 2 diabetes means reaching target on one drug. It is not a compromise or a starter package; for many newly diagnosed people it is the correct treatment for years, and fewer tablets means better adherence, which in turn means better control.
The question worth answering carefully is which one drug. For twenty years the answer was metformin for everyone. That has changed. Metformin is still the default, and for a meaningful group of patients the first drug is now chosen for what it protects rather than for how much it lowers glucose.
🎯 The target, in numbers
Treatment is judged on HbA1c, a measure of average glucose over the previous two to three months. The target is individualised, and the range is wider than most people expect.
| Situation | Usual HbA1c target |
|---|---|
| Newly diagnosed, young, no complications | 6.5 percent or 48 mmol/mol, tighter if achievable without hypoglycaemia |
| Most adults | 7.0 percent or 53 mmol/mol |
| On a drug that can cause hypoglycaemia | 7.5 percent or 58 mmol/mol |
| Older, frail, limited life expectancy, multiple conditions | 8.0 percent or 64 mmol/mol; avoiding lows matters more than the number |
📊 Why the target loosens with age. The benefit of tight control accumulates over decades, while the harm from a severe low is immediate: falls, fractures, confusion, cardiac events. In someone of 80 with heart disease, driving HbA1c to 6.5 percent with a sulfonylurea causes more harm than the high sugar would. Trials that pushed very tight control in older high-risk patients found worse outcomes, not better.
💊 Metformin: the default, and how to actually start it
Metformin reduces glucose production by the liver overnight and improves insulin sensitivity in muscle. It does not stimulate insulin release, so it does not cause hypoglycaemia on its own. It is weight neutral or slightly weight-reducing, it lowers HbA1c by roughly 1 to 1.5 percentage points, it is cheap, and it has the longest safety record of any oral diabetes drug.
Available in our diabetes category as Glucophage (Metformin 500/850/1000 mg) and the generic Glycoheal (Metformin).
📈 Start low, go slow — this is the whole difference between success and abandonment. Around a quarter of people get diarrhoea, nausea, cramping or a metallic taste, and almost all of it comes from starting at too high a dose too fast. The approach that works:
- 500 mg once daily with the evening meal for the first week
- Add 500 mg with breakfast in week two
- Increase by 500 mg per week as tolerated, up to 2000 mg daily, maximum 2550 mg
- Always with food, never on an empty stomach
- If side effects appear, drop back one step and hold for two weeks rather than stopping
- Extended-release metformin taken once daily with the evening meal causes roughly half as many gut symptoms and is the answer for anyone who could not tolerate the standard form
🩺 Kidney function decides the dose
| eGFR | What happens to metformin |
|---|---|
| Above 60 | Full dose, check kidney function yearly |
| 45 to 59 | Continue, check every 3 to 6 months |
| 30 to 44 | Review: usually halve the dose, do not start it new at this level |
| Below 30 | Stop |
⚠️ Sick day rules for metformin. Lactic acidosis is rare but serious, and it happens when metformin accumulates during a period of dehydration or reduced kidney perfusion. Stop metformin temporarily during vomiting or diarrhoea, any illness with fever and reduced fluid intake, before and for 48 hours after a scan using iodinated contrast dye, and before surgery. Restart once eating and drinking normally, with kidney function rechecked after contrast. Alcohol binges add to the same risk. Symptoms to act on immediately: deep rapid breathing, severe muscle aching, unusual drowsiness, vomiting with abdominal pain.
🧪 The deficiency people are not told about
Long-term metformin impairs absorption of vitamin B12, in roughly one in ten to one in three users after several years. Deficiency causes fatigue, sore tongue and, importantly, numbness and tingling in the feet — which is easily mistaken for diabetic neuropathy and treated as irreversible when it is correctable with an injection or supplement. B12 is worth checking every one to two years on metformin, and immediately if neuropathy symptoms appear.
❤️ When the first drug is not metformin
This is the part most older articles miss. Current guidance says that where certain conditions are present, an SGLT2 inhibitor is indicated regardless of what the HbA1c is, because the benefit is on the organ rather than on the glucose.
| If the person has | First-choice drug | Reason |
|---|---|---|
| Heart failure, either type | SGLT2 inhibitor | Reduces hospitalisation and death from heart failure |
| Chronic kidney disease or protein in the urine | SGLT2 inhibitor | Slows progression of kidney disease substantially |
| Established cardiovascular disease | SGLT2 inhibitor | Reduces cardiovascular events |
| Obesity as the dominant problem | GLP-1 receptor agonist | Largest weight reduction; not currently in our catalogue |
| None of the above | Metformin | Efficacy, safety record, cost |
Our SGLT2 options are Dapavel (Dapagliflozin 5/10 mg), Dapasmart (Dapagliflozin), Dapanta (Dapagliflozin) and Canagliflowin (Canagliflozin 100/300 mg), with the fixed combination Oxramet XR (Dapagliflozin and Metformin).
💧 Using an SGLT2 inhibitor safely
These drugs make the kidney excrete glucose in the urine, which lowers blood sugar, reduces weight by 2 to 3 kg and lowers blood pressure slightly. The consequences follow directly from sugar in the urine:
- 🍄 Genital yeast infections, the commonest side effect, in both sexes. Usually easy to treat; good hygiene and drying reduce recurrence
- 🚽 Urinary infections, modestly more frequent
- 💧 Increased urination and mild dehydration; care in older people and in anyone on a diuretic
- 📉 A small expected dip in eGFR in the first weeks, which is not kidney damage and does not mean stopping
🚨 Euglycaemic ketoacidosis: the one that gets missed. SGLT2 inhibitors can cause diabetic ketoacidosis while blood glucose looks normal or only slightly raised, which is why it is overlooked. Nausea, vomiting, abdominal pain, deep rapid breathing and a fruity smell to the breath need urgent assessment and a ketone test regardless of the glucose reading. It is triggered by acute illness, surgery, fasting, very low-carbohydrate diets and heavy alcohol. Stop the drug during acute illness and for at least three days before planned surgery, and do not start a ketogenic diet while taking one.
🗂️ The other classes, and where each earns a place
- Sulfonylureas — Amaryl (Glimepiride), Glucotrol (Glipizide)
- Force the pancreas to release insulin. Powerful, immediate and cheap, lowering HbA1c by 1 to 1.5 points. The trade-offs are hypoglycaemia and weight gain of 2 to 3 kg, and the effect wears off over years as beta cells tire. Hypoglycaemia risk is higher in older people, in kidney impairment and when meals are skipped, and it has implications for driving. They remain a reasonable choice where cost is decisive or glucose needs bringing down quickly.
- DPP-4 inhibitors — Januvia (Sitagliptin), Sitasmart (Sitagliptin)
- Once daily, weight neutral, virtually no hypoglycaemia, very well tolerated. The weakest glucose effect of the group, around 0.5 to 0.8 points. Ideal for an older patient where the priority is avoiding lows. Not combined with a GLP-1 agonist, since they work on the same pathway. Dose is reduced in kidney impairment.
- Pioglitazone — Actos (Pioglitazone), Avandia (Rosiglitazone)
- Genuinely improve insulin resistance, with a durable effect and no hypoglycaemia, and pioglitazone also helps fatty liver. Limited by fluid retention and weight gain, a higher fracture risk, and a firm contraindication in heart failure. Useful in marked insulin resistance without cardiac disease.
- Meglitinides — Prandin (Repaglinide), Starlix (Nateglinide)
- Short-acting insulin releasers taken with each meal, and skipped when a meal is skipped. Suit irregular eating patterns and people whose problem is post-meal spikes rather than fasting glucose.
- Acarbose — Precose (Acarbose)
- Blocks carbohydrate digestion in the gut, blunting post-meal peaks. Taken with the first mouthful of each meal. Flatulence and bloating limit its use, and they ease with slow titration.
🍬 One rule specific to acarbose. If hypoglycaemia occurs while taking it alongside another drug, it must be treated with pure glucose, such as glucose tablets or gel — not with ordinary sugar, sweets or fruit juice. Acarbose blocks the enzyme that splits sucrose into absorbable sugars, so table sugar will not raise blood glucose quickly.
📅 When one drug is not the right plan
Monotherapy is the wrong starting point in three situations:
- HbA1c more than 1.5 percentage points above target at diagnosis — two drugs from the start reach target faster and delay treatment failure
- HbA1c above 10 percent, or blood glucose above about 300 mg/dL with symptoms such as thirst, frequent urination and weight loss — insulin is usually started, often temporarily, and many people come off it once glucose toxicity resolves
- Evidence of ketones or weight loss suggesting type 1 or a related form — needs reassessment of the diagnosis rather than another oral drug
Monotherapy also has a shelf life. Around half of people need a second agent within three years, and this is disease progression, not personal failure. Adding a drug promptly when HbA1c drifts above target avoids years of accumulated exposure to high glucose.
💪 The intervention that beats every tablet
Substantial weight loss can put type 2 diabetes into remission — normal HbA1c with no glucose-lowering medication at all.
| Weight lost | Chance of remission |
|---|---|
| Under 5 kg | Around 7 percent |
| 10 to 15 kg | Around 57 percent |
| 15 kg or more | Around 86 percent |
Those figures come from a structured trial of a low-calorie programme with clinical support, and remission was maintained in about a third of participants at two years. Two conditions matter: it works best within six years of diagnosis, while beta cells retain reserve, and the weight has to stay off, since regain brings the diabetes back.
Alongside that, the measures with the clearest effect on insulin sensitivity are resistance training twice a week, 150 minutes of moderate aerobic activity, reducing refined carbohydrate, and treating sleep apnoea if present. Our guide to weight loss covers the practical side.
📈 What monitoring looks like
- 🩸 HbA1c every 3 months until stable, then every 6 months
- 🧫 Kidney function and urine protein yearly, more often on metformin with reduced eGFR
- 👁️ Retinal screening yearly — painless, silent, and the reason blindness from diabetes is preventable
- 🦶 Foot check yearly, and more often with any loss of sensation
- 🩹 Blood pressure and lipids at each review — in type 2 diabetes these do more for life expectancy than the glucose itself
- 💉 Vitamin B12 every one to two years on long-term metformin
🚨 When to get help the same day
- Vomiting and unable to keep fluids down while on metformin or an SGLT2 inhibitor
- Nausea, abdominal pain and deep rapid breathing, even with a normal glucose reading, on an SGLT2 inhibitor
- Repeated hypoglycaemia, or a single episode needing someone else to help
- A foot wound, blister, redness or black area, which in diabetes is urgent regardless of pain
- Sudden change in vision or new floaters
- Blood glucose persistently above 300 mg/dL with thirst and frequent urination
- Numbness or tingling in the feet — needs assessment, and B12 checking if on metformin
❓ Frequently asked questions
How should metformin be started?
500 mg once daily with the evening meal, adding 500 mg each week up to 2000 mg daily, always with food. Starting high is the main cause of the diarrhoea and nausea that make people give up. Extended-release taken once daily causes roughly half as many gut symptoms.
Does metformin cause low blood sugar?
Not on its own. It reduces glucose production by the liver rather than stimulating insulin release. Hypoglycaemia becomes a risk when it is combined with a sulfonylurea or insulin.
When should metformin be stopped temporarily?
During vomiting or diarrhoea, any illness with fever and reduced fluid intake, before and for 48 hours after a scan using contrast dye, and before surgery. These are the situations in which it can accumulate and cause lactic acidosis.
Can I take metformin with kidney problems?
Up to an eGFR of 45 it continues at full dose with more frequent monitoring. Between 30 and 44 the dose is usually halved and it is not newly started. Below 30 it is stopped.
Why do my feet tingle if my sugars are controlled?
It may not be diabetic neuropathy. Long-term metformin impairs vitamin B12 absorption, and the resulting deficiency causes numbness and tingling that is correctable. B12 is worth checking every one to two years on metformin and immediately if these symptoms appear.
Is metformin always the first drug?
No longer. With heart failure, chronic kidney disease or established cardiovascular disease, an SGLT2 inhibitor is now chosen first regardless of the HbA1c, because the benefit is on the heart and kidneys rather than on glucose alone.
What are the side effects of SGLT2 inhibitors?
Genital yeast infections are the commonest, since sugar is excreted in the urine, along with more frequent urination and mild dehydration. A small early dip in kidney function is expected and is not damage. Rarely they cause ketoacidosis with a normal glucose level.
What is euglycaemic ketoacidosis?
Diabetic ketoacidosis occurring while blood glucose looks normal, a rare effect of SGLT2 inhibitors. Nausea, vomiting, abdominal pain and deep rapid breathing need urgent assessment and a ketone test whatever the glucose reads. Stop the drug during acute illness and before surgery.
Can type 2 diabetes go into remission?
Yes. In a structured weight loss trial, remission was achieved by around 57 percent of those losing 10 to 15 kg and 86 percent of those losing more. It works best within six years of diagnosis, and the weight has to stay off.
How long will one drug be enough?
Around half of people need a second medicine within three years. That reflects the natural course of the condition, not a failure of effort, and adding a drug promptly when HbA1c drifts up avoids years of high glucose exposure.
📑 Sources and editorial
- ADA and EASD consensus guidance on the management of hyperglycaemia in type 2 diabetes, including organ-protection indications for SGLT2 inhibitors
- Prescribing information for metformin, dapagliflozin, canagliflozin, sitagliptin, glimepiride, pioglitazone, repaglinide and acarbose
- Guidance on metformin and renal function thresholds, contrast imaging and sick day rules
- Cardiovascular and renal outcome trials of SGLT2 inhibitors, and reports of euglycaemic ketoacidosis
- The DiRECT trial of weight management and type 2 diabetes remission, and its two-year follow-up
- Studies of metformin-associated vitamin B12 deficiency
- Related reading: weight loss
- Related products: Glucophage (Metformin), Dapavel (Dapagliflozin), Januvia (Sitagliptin), Amaryl (Glimepiride), diabetes category
- RXshop Editorial Team — reviewed by Daniel Kim, MD — Endocrinologist & Diabetes Specialist
Medical Disclaimer: The information in this article is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare provider with any questions you may have regarding a medical condition, and before starting, stopping or changing any medication.